TY  - GEN
AU  - Fizazi,Karim
AU  - Lipton,Allan
AU  - Mariette,Xavier
AU  - Body,Jean-Jacques
AU  - Rahim,Yasmin
AU  - Gralow,Julie R
AU  - Gao,Guozhi
AU  - Wu,Ling
AU  - Sohn,Winnie
AU  - Jun,Susie
TI  - Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates
SN  - 1527-7755
PY  - 2009///0429
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - pharmacokinetics
KW  - Antibodies, Monoclonal, Humanized
KW  - Bone Density Conservation Agents
KW  - therapeutic use
KW  - Bone Neoplasms
KW  - complications
KW  - Bone Resorption
KW  - chemically induced
KW  - Breast Neoplasms
KW  - pathology
KW  - Collagen Type I
KW  - urine
KW  - Denosumab
KW  - Diphosphonates
KW  - administration & dosage
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - Peptides
KW  - Prostatic Neoplasms
KW  - RANK Ligand
KW  - antagonists & inhibitors
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2008.19.2146
ER  -